INCIDENCE AND OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND MAJOR BLEEDING COMPLICATIONS: FINDINGS FROM THE TREAT-AF STUDY

Although oral anticoagulation (OAC) is indicated for most patients with atrial fibrillation (AF) and risk factors, there is limited data on the incidence of thromboembolic and recurrent bleeding events in AF patients after experiencing a major bleeding complication. We assessed the effect of major